Is the measles vaccine safe for a 2 month old baby girl

The short version: the measles vaccine is not approved or studied for a 2-month-old, and giving it that early carries known risks from the live virus with no proven benefit at that age.

The measles vaccine is a live attenuated virus. It is not recommended for infants under 6 months of age anywhere in the world. The standard first dose is given at 12 to 15 months. The reason is straightforward: maternal antibodies still circulate in a 2-month-old and can neutralize the vaccine virus, making the shot ineffective [17]. At the same time, the infant's immune system is immature, and a live virus carries a real risk of causing the disease it is meant to prevent.

The evidence you need to see is from a 2020 study of an emergency campaign in Okinawa, Japan, where infants aged 6 to 11 months were given the measles vaccine during an outbreak. Among 8,062 recipients, six developed vaccine-associated measles, an incidence of about 0.74 per 1,000 doses [14]. That is a known, documented harm from the live virus. A 2-month-old is even more vulnerable than a 6-month-old. The same study found that among 11,984 children aged 5 to 6 years receiving a second dose, zero cases of vaccine-associated measles occurred [14]. The risk is concentrated in the youngest recipients.

There is no safety data for a 2-month-old because no one has studied it. The evidence you have is all for older children: 9 to 12 months [9], 12 to 15 months [17], or 6 to 11 months in an outbreak [14]. The manufacturer's own 32-year postmarketing review, funded by Merck, reported 17,536 adverse events including 773 febrile convulsions and 259 cases of thrombocytopenia across all ages [28]. That review covers 575 million doses, but it does not break out risks for a 2-month-old because the vaccine is not given at that age.

The burden of proof is on the person asking you to inject a live virus into a 2-month-old. That burden has not been met. There is no study, no trial, no safety database for this age. The known risks from the live virus in slightly older infants are real. The benefit at 2 months is zero because maternal antibodies block the vaccine.

My call: do not give the measles vaccine to a 2-month-old. There is no evidence it works at that age, and there is documented evidence it can cause the disease in slightly older infants. Confidence: high.